BioLumic Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 32

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $13.7M

  • Investors
  • 29

BioLumic General Information

Description

Developer of UV crop enhancement systems designed to address growing agricultural concerns. The company's systems utilize UV radiations, which can regulate numerous responses in living organisms and apply them to young plants, priming them to thrive and survive, enabling farmers to increase crop yields, fungal resistance in transplant seedlings and enhance color and taste in indoor grown products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Agriculture
Other Industries
Cultivation
Primary Office
  • 21 Dairy Farm Road
  • Palmerston North, 4440
  • New Zealand
+64 06-352 0000

BioLumic Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioLumic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 07-Mar-2022 $13.7M 000.00 000.00 Completed Generating Revenue
7. Grant 01-Sep-2020 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 01-May-2020 00.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 01-Dec-2017 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 01-Dec-2014 00000 00.000 00.000 Completed Startup
3. Grant 00000 Completed Startup
2. Seed Round 16-Oct-2013 $350K $350K 00.000 Completed Startup
1. Early Stage VC 26-Sep-2013 Completed Startup
To view BioLumic’s complete valuation and funding history, request access »

BioLumic Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B-2 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-3 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-2 849,193 $0.000100 8% $3.16 $3.16 1x $3.16 10.83%
Series A-1 191,235 $0.000100 8% $2.52 $2.52 1x $2.52 2.44%
To view BioLumic’s complete cap table history, request access »

BioLumic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of UV crop enhancement systems designed to address growing agricultural concerns. The company's systems utiliz
Other Agriculture
Palmerston North, New Zealand
32 As of 2022
000.00
00.00 0000-00-00
00000000000 000.00

00000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
00000000000
Emeryville, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000000

agna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex e
00000 00000000000
Boston, MA
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioLumic Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sound Agriculture Venture Capital-Backed Emeryville, CA 00 000.00 00000000000 000.00
0000000 00000 Venture Capital-Backed Boston, MA 00 0000 000000000 - 0000
00000000000 Venture Capital-Backed North Bend, NE 0 000 0000000000 0 000
You’re viewing 3 of 3 competitors. Get the full list »

BioLumic Patents

BioLumic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019376891-A1 Uv-b induced plant pathogen resistance Pending 09-Nov-2018 000000000
CA-3119316-A1 Uv-b induced plant pathogen resistance Pending 09-Nov-2018 000000000
EP-3876697-A2 Uv-b induced plant pathogen resistance Pending 09-Nov-2018 000000000
US-20210298243-A1 Uv-b induced plant pathogen resistance Pending 09-Nov-2018 000000000
US-20200190532-A1 High growth and high hardiness transgenic plants Pending 21-Aug-2017 C12N15/8273
To view BioLumic’s complete patent history, request access »

BioLumic Executive Team (7)

Name Title Board Seat Contact Info
Steven Sibulkin Chief Executive Officer
Richard Perry Chief Financial Officer
Jason Wargent Ph.D Founder & Chief Scientific Officer
You’re viewing 3 of 7 executive team members. Get the full list »

BioLumic Board Members (13)

Name Representing Role Since
Adrian Percy Finistere Ventures Chairman 000 0000
Dean Tilyard Self Board Member 000 0000
Eli Nir Self Board Member 000 0000
Ingrid Fung Finistere Ventures Board Observer 000 0000
John Bedbrook Ph.D Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

BioLumic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioLumic Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arcview Ventures Venture Capital Minority 000 0000 000000 0
Booster NZ Asset Manager Minority 000 0000 000000 0
Bravos Capital Venture Capital Minority 000 0000 000000 0
Entourage Effect Capital Venture Capital Minority 000 0000 000000 0
Flatiron Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 29 investors. Get the full list »